Neurocrine Biosciences Inc (NBIX)
140.06
+6.36
(+4.76%)
USD |
NASDAQ |
Apr 23, 16:00
140.06
0.00 (0.00%)
After-Hours: 16:21
Neurocrine Biosciences Profit Margin (Quarterly): 28.67% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 28.67% |
| September 30, 2023 | 16.66% |
| June 30, 2023 | 21.10% |
| March 31, 2023 | -18.22% |
| December 31, 2022 | 21.60% |
| September 30, 2022 | 17.66% |
| June 30, 2022 | -4.47% |
| March 31, 2022 | 4.48% |
| December 31, 2021 | -2.34% |
| September 30, 2021 | 7.60% |
| June 30, 2021 | 14.64% |
| March 31, 2021 | 13.57% |
| December 31, 2020 | |
| September 30, 2020 | -22.28% |
| June 30, 2020 | 26.32% |
| March 31, 2020 | 15.77% |
| December 31, 2019 | 13.93% |
| September 30, 2019 | 24.22% |
| June 30, 2019 | 27.96% |
| March 31, 2019 | -73.77% |
| December 31, 2018 | 13.74% |
| September 30, 2018 | 33.45% |
| June 30, 2018 | -6.10% |
| March 31, 2018 | -58.83% |
| December 31, 2017 | 7.29% |
| Date | Value |
|---|---|
| September 30, 2017 | -18.31% |
| June 30, 2017 | -946.9% |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | -128.4% |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | -6.03% |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | -1.46K% |
| September 30, 2013 | -1.53K% |
| June 30, 2013 | -1.68K% |
| March 31, 2013 | -1.65K% |
| December 31, 2012 | 43.24% |
| September 30, 2012 | -32.90% |
| June 30, 2012 | -4.74% |
| March 31, 2012 | -7.86% |
| December 31, 2011 | 11.98% |
| September 30, 2011 | 75.38% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-22.28%
Minimum
Sep 2020
28.67%
Maximum
Dec 2023
11.49%
Average
15.21%
Median
Profit Margin (Quarterly) Benchmarks
| Globus Medical Inc | 2.44% |
| Inspire Medical Systems Inc | 7.67% |
| AIM ImmunoTech Inc | -19.35K% |
| Protalix BioTherapeutics Inc | -57.64% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.17% |
| Return on Assets | 9.29% |
| Return on Invested Capital | 12.09% |
| Gross Profit Margin (Quarterly) | 98.35% |
| Operating Margin (Quarterly) | 29.17% |
| Return on Net Operating Assets | 38.13% |